XML 52 R53.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Reporting (Details) (USD $)
3 Months Ended 12 Months Ended
Dec. 31, 2011
Sep. 30, 2011
Jun. 30, 2011
Mar. 31, 2011
Dec. 31, 2010
Sep. 30, 2010
Jun. 30, 2010
Mar. 31, 2010
Dec. 31, 2011
segment
Dec. 31, 2010
Dec. 31, 2009
Segment Reporting                      
Number of segments                 3    
Segment reporting information                      
Net revenues $ 28,317,000,000 $ 26,674,000,000 $ 26,414,000,000 $ 25,695,000,000 $ 24,589,000,000 $ 23,711,000,000 $ 23,885,000,000 $ 23,593,000,000 $ 107,100,000,000 $ 95,778,000,000 $ 98,215,000,000
Gross profit 5,555,000,000 5,178,000,000 5,086,000,000 4,742,000,000 5,454,000,000 5,015,000,000 5,012,000,000 4,738,000,000 20,561,000,000 20,219,000,000 20,358,000,000
Operating profit 1,957,000,000 1,584,000,000 1,484,000,000 1,305,000,000 1,761,000,000 1,478,000,000 1,494,000,000 1,404,000,000 6,330,000,000 6,137,000,000 6,425,000,000
Depreciation and amortization                 1,568,000,000 1,469,000,000 1,389,000,000
Total assets 64,543,000,000       62,169,000,000       64,543,000,000 62,169,000,000 61,641,000,000
Goodwill 26,458,000,000       25,669,000,000       26,458,000,000 25,669,000,000 25,680,000,000
Additions to property and equipment                 1,872,000,000 2,005,000,000 2,548,000,000
Intersegment eliminations, intersegment revenues                 2,600,000,000 1,800,000,000 700,000,000
Pharmacy Services Segment
                     
Segment reporting information                      
Net revenues                 58,874,000,000 47,145,000,000 50,551,000,000
Gross profit                 3,279,000,000 3,315,000,000 3,813,000,000
Operating profit                 2,220,000,000 2,361,000,000 2,853,000,000
Depreciation and amortization                 433,000,000 390,000,000 377,000,000
Total assets 35,704,000,000       32,254,000,000       35,704,000,000 32,254,000,000 33,082,000,000
Goodwill 19,657,000,000       18,868,000,000       19,657,000,000 18,868,000,000 18,879,000,000
Additions to property and equipment                 461,000,000 234,000,000 218,000,000
Net revenues, retail co-payments                 7,900,000,000 6,600,000,000 6,900,000,000
Intersegment eliminations, intersegment revenues                   1,800,000,000 700,000,000
Intersegment eliminations, intersegment gross profit                 186,000,000 135,000,000 48,000,000
Retail Pharmacy Segment
                     
Segment reporting information                      
Net revenues                 59,599,000,000 57,345,000,000 55,355,000,000
Gross profit                 17,468,000,000 17,039,000,000 16,593,000,000
Operating profit                 4,912,000,000 4,537,000,000 4,159,000,000
Depreciation and amortization                 1,060,000,000 1,016,000,000 965,000,000
Total assets 28,323,000,000       28,927,000,000       28,323,000,000 28,927,000,000 28,302,000,000
Goodwill 6,801,000,000       6,801,000,000       6,801,000,000 6,801,000,000 6,801,000,000
Additions to property and equipment                 1,353,000,000 1,708,000,000 2,183,000,000
Intersegment eliminations, intersegment revenues                   1,800,000,000 700,000,000
Intersegment eliminations, intersegment gross profit                 186,000,000 135,000,000 48,000,000
Corporate Segment
                     
Segment reporting information                      
Operating profit                 (616,000,000) (626,000,000) (539,000,000)
Depreciation and amortization                 75,000,000 63,000,000 47,000,000
Total assets 1,121,000,000       1,439,000,000       1,121,000,000 1,439,000,000 774,000,000
Additions to property and equipment                 58,000,000 63,000,000 147,000,000
Intersegment Eliminations
                     
Segment reporting information                      
Net revenues                 (11,373,000,000) (8,712,000,000) (7,691,000,000)
Gross profit                 (186,000,000) (135,000,000) (48,000,000)
Operating profit                 (186,000,000) (135,000,000) (48,000,000)
Total assets $ (605,000,000)       $ (451,000,000)       $ (605,000,000) $ (451,000,000) $ (517,000,000)
Number of type of transactions related to intersegment eliminations                 2